Pfizer Limited Total Liabilities
Pfizer Limited total liabilities. Based on the latest financial reports, Pfizer Limited (PFIZER) has total liabilities worth Rs-42.03 Billion INR (≈ $-454.53 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Pfizer Limited's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Pfizer Limited (2005–2026)
Total liabilities of Pfizer Limited from 2005 to 2026. This chart illustrates how Pfizer Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Pfizer Limited (PFIZER) investment intensity to see how much of total assets are deployed in long-term investments.
Pfizer Limited Competitors by Total Liabilities
The table below lists competitors of Pfizer Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ruentex Industries Ltd
TW:2915
|
Taiwan | NT$14.94 Billion |
|
Palvella Therapeutics, Inc
NASDAQ:PVLA
|
USA | $36.58 Million |
|
Star Petroleum Refining Co Ltd
BK:SPRC
|
Thailand | ฿32.17 Billion |
|
Wuxi Rural Commercial Bank Co Ltd
SHG:600908
|
China | CN¥267.88 Billion |
|
Galapagos NV ADR
NASDAQ:GLPG
|
USA | $119.06 Million |
|
Perusahaan Gas Negara Persero
JK:PGAS
|
Indonesia | Rp42.17 Trillion |
|
Qingdao Sentury Tire Co Ltd
SHE:002984
|
China | CN¥4.60 Billion |
|
Centrus Energy Corp.
NYSE:LEU
|
USA | $1.69 Billion |
Liability Composition Analysis (2005–2026)
This chart breaks down Pfizer Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Pfizer Limited asset portfolio.
Liquidity & Leverage Metrics
Pfizer Limited Total Liabilities Ratios Explained
Pfizer Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pfizer Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pfizer Limited (2005–2026)
The table below shows the annual total liabilities of Pfizer Limited from 2005 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs7.19 Billion ≈ $77.75 Million |
+3.64% |
| 2025-03-31 | Rs6.94 Billion ≈ $75.02 Million |
+9.55% |
| 2024-03-31 | Rs6.33 Billion ≈ $68.48 Million |
-20.19% |
| 2023-03-31 | Rs7.93 Billion ≈ $85.81 Million |
-23.42% |
| 2022-03-31 | Rs10.36 Billion ≈ $112.05 Million |
+18.70% |
| 2021-03-31 | Rs8.73 Billion ≈ $94.40 Million |
-13.57% |
| 2020-03-31 | Rs10.10 Billion ≈ $109.22 Million |
+8.75% |
| 2019-03-31 | Rs9.29 Billion ≈ $100.43 Million |
-7.76% |
| 2018-03-31 | Rs10.07 Billion ≈ $108.88 Million |
+18.20% |
| 2017-03-31 | Rs8.52 Billion ≈ $92.11 Million |
+7.04% |
| 2016-03-31 | Rs7.96 Billion ≈ $86.05 Million |
+24.62% |
| 2015-03-31 | Rs6.39 Billion ≈ $69.06 Million |
+140.11% |
| 2014-03-31 | Rs2.66 Billion ≈ $28.76 Million |
-27.16% |
| 2013-03-31 | Rs3.65 Billion ≈ $39.48 Million |
+34.34% |
| 2012-03-31 | Rs2.72 Billion ≈ $29.39 Million |
+21.97% |
| 2011-03-31 | Rs2.23 Billion ≈ $24.10 Million |
+6.59% |
| 2010-03-31 | Rs2.09 Billion ≈ $22.61 Million |
+6.35% |
| 2009-03-31 | Rs1.97 Billion ≈ $21.26 Million |
-9.73% |
| 2008-03-31 | Rs2.18 Billion ≈ $23.55 Million |
+5.32% |
| 2007-03-31 | Rs2.07 Billion ≈ $22.36 Million |
+3.32% |
| 2006-03-31 | Rs2.00 Billion ≈ $21.64 Million |
+9.56% |
| 2005-03-31 | Rs1.83 Billion ≈ $19.75 Million |
-- |
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterolog… Read more